Regeneron Pharmaceuticals, Inc. (LON:0R2M)
London flag London · Delayed Price · Currency is GBP · Price in USD
773.76
+16.76 (2.21%)
Mar 9, 2026, 4:55 PM GMT

Regeneron Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
3,1182,4882,7303,1062,886
Upgrade
Short-Term Investments
5,4876,5248,1154,6362,809
Upgrade
Cash & Short-Term Investments
8,6059,01310,8457,7425,695
Upgrade
Cash Growth
-4.52%-16.90%40.07%35.96%58.76%
Upgrade
Accounts Receivable
5,7416,2125,2995,0235,059
Upgrade
Other Receivables
--368.5305.6977.5
Upgrade
Receivables
5,7416,2125,6675,3296,037
Upgrade
Inventory
3,2013,0872,5812,4021,951
Upgrade
Prepaid Expenses
469.2348.4386.6411.2332.4
Upgrade
Restricted Cash
5.60.8---
Upgrade
Total Current Assets
18,02218,66119,47915,88414,015
Upgrade
Property, Plant & Equipment
5,3664,8174,2243,8343,482
Upgrade
Long-Term Investments
10,5959,0605,4716,6406,878
Upgrade
Other Intangible Assets
1,2571,1491,039915.56.7
Upgrade
Long-Term Deferred Tax Assets
4,0773,3142,5751,724876.9
Upgrade
Other Long-Term Assets
1,241758.8291.8216.9176.1
Upgrade
Total Assets
40,55937,75933,08029,21525,435
Upgrade
Accounts Payable
939789.5606.6589.2564
Upgrade
Accrued Expenses
2,8392,4972,3272,0541,593
Upgrade
Current Portion of Leases
37.830.31912.4719.7
Upgrade
Current Income Taxes Payable
--11.7-326.3
Upgrade
Current Unearned Revenue
553627.7458.9485.3442
Upgrade
Other Current Liabilities
----287.4
Upgrade
Total Current Liabilities
4,3683,9443,4233,1413,933
Upgrade
Long-Term Debt
1,9861,9841,9831,9811,980
Upgrade
Long-Term Leases
949924.1788.7775.8-
Upgrade
Long-Term Unearned Revenue
208.7185.7126.769.873.3
Upgrade
Other Long-Term Liabilities
1,7901,367785.4582.2680.2
Upgrade
Total Liabilities
9,3028,4067,1076,5516,666
Upgrade
Common Stock
0.10.10.10.10.1
Upgrade
Additional Paid-In Capital
13,99512,85611,3549,9498,088
Upgrade
Retained Earnings
35,79731,67327,26023,30718,968
Upgrade
Treasury Stock
-18,613-15,167-12,560-10,353-8,261
Upgrade
Comprehensive Income & Other
77.5-7.9-80.9-238.8-26.2
Upgrade
Shareholders' Equity
31,25729,35425,97322,66418,769
Upgrade
Total Liabilities & Equity
40,55937,75933,08029,21525,435
Upgrade
Total Debt
2,9732,9392,7912,7702,700
Upgrade
Net Cash (Debt)
15,89314,97413,45111,5659,833
Upgrade
Net Cash Growth
6.14%11.32%16.31%17.61%144.18%
Upgrade
Net Cash Per Share
146.35130.09118.30101.8987.64
Upgrade
Filing Date Shares Outstanding
102.62106.82107.46106.73106.44
Upgrade
Total Common Shares Outstanding
102.6107.1107.12107106.57
Upgrade
Working Capital
13,65414,71716,05612,74310,082
Upgrade
Book Value Per Share
304.65274.08242.47211.81176.11
Upgrade
Tangible Book Value
30,00028,20524,93521,74918,762
Upgrade
Tangible Book Value Per Share
292.39263.35232.78203.26176.05
Upgrade
Land
278.8288.2283.1264.5248
Upgrade
Buildings
3,1062,5732,4232,2702,089
Upgrade
Machinery
2,2852,1491,9401,8031,662
Upgrade
Construction In Progress
1,8901,7221,345980.5767.7
Upgrade
Leasehold Improvements
174.4154.5133.9114.3113.9
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.